The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis
- 1 January 1988
- journal article
- conference paper
- Published by Springer Nature in Rheumatology International
- Vol. 8 (1) , 1-9
- https://doi.org/10.1007/bf00541343
Abstract
The concentrations of aminoterminal-type-III procollagen (procollagen N-) peptide, and of proteoglycans were measured in knee-joint synovial fluid and serum from patients with rheumatoid arthritis or reactive arthritis. All synovial fluids contained large amounts of intact propeptide. The synovial fluid : serum propeptide ratios were high, suggesting local propeptide liberation. A correlation was demonstrated between the propeptide concentration in synovial fluid and in serum. In rheumatoid arthritis, the propeptide concentration in synovial fluid was related to local inflammatory activity, and the serum concentration was correlated with the presence of nonspecific markers of inflammation. The presence of smaller propeptide fragments in synovial fluid indicated that some degradation occurred locally. The local metabolic changes were most prominent in patients with joint erosions. Patients with nonerosive rheumatoid arthritis and reactive arthritis had similar synovial fluid propeptide concentrations. The proteoglycan content of synovial fluid was inversely related to the degree of joint destruction, and was highest in patients with reactive arthritis. No correlation was observed between the concentrations of propeptide and proteoglycan in synovial fluid. Intra-articular glucocorticoid injection reduced the levels of propeptide and proteoglycan in synovial fluid.Keywords
This publication has 31 references indexed in Scilit:
- Serum aminoterminal type III procollagen peptideAPMIS, 1988
- Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.Annals of the Rheumatic Diseases, 1988
- Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid.Annals of the Rheumatic Diseases, 1986
- DIFFERENCE IN CARTILAGE PROTEOGLYCAN LEVEL IN SYNOVIAL FLUID IN EARLY RHEUMATOID ARTHRITIS AND REACTIVE ARTHRITISThe Lancet, 1985
- Reticulin and its related structural connective tissue proteins in the rheumatoid synoviumeHistopathology, 1984
- Neutral protease cleaving the N-terminal propeptide of type III procollagen: partial purification and characterization of the enzyme from smooth muscle cells of bovine aortaBiochemistry, 1984
- Evidence for the local production and utilization of immune reactants in rheumatoid arthritisArthritis & Rheumatism, 1982
- The collagens of the jointArthritis & Rheumatism, 1980
- Radioimmunoassay for type III procollagen peptide and its application to human liver diseaseEuropean Journal of Clinical Investigation, 1979
- Occurrence of type III collagen in inflamed synovial membranes: A comparison between non rheumatoid, rheumatoid, and normal synovial collagensBiochemical and Biophysical Research Communications, 1975